{
  "id": "map_1812",
  "title": "ANEMIA ORIGINADA POR OTRAS\\NDEFICIENCIAS NUTRICIONALES",
  "specialty": "Cardiolog√≠a",
  "tag": "üìã Gu√≠a Cl√≠nica",
  "node_count": 151,
  "root": {
    "text": "ANEMIA ORIGINADA POR OTRAS\\NDEFICIENCIAS NUTRICIONALES",
    "children": [
      {
        "text": "## DEFICIENCIA\\NDE VITAMINA A",
        "children": [
          {
            "text": "- Prevalente en ni√±os de edad escolar en pa√≠ses africanos subdesarrollados (p. ej., Malaui)",
            "children": []
          },
          {
            "text": "- Caracter√≠sticas",
            "children": [
              {
                "text": "- Reducci√≥n del volumen corpuscular medio (MCV)",
                "children": []
              },
              {
                "text": "- Reducci√≥n de la concentraci√≥n media de hemoglobina corpuscular",
                "children": []
              },
              {
                "text": "- Anisocitosis y poiquilocitosis",
                "children": []
              }
            ]
          },
          {
            "text": "- Diferencias con\\Ndeficiencia de hierro",
            "children": [
              {
                "text": "- Concentraci√≥n s√©rica de hierro est√° disminuida",
                "children": []
              },
              {
                "text": "- Capacidad s√©rica total de uni√≥n al hierro es normal o baja",
                "children": []
              },
              {
                "text": "- Reservas de hierro (ferritina s√©rica) est√°n aumentadas",
                "children": []
              },
              {
                "text": "- No responde al tratamiento con hierro medicinal",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Responde a reposici√≥n de vitamina A",
                "children": []
              },
              {
                "text": "- Act√∫a por medio de los receptores de √°cido retinoico en c√©lulas progenitoras eritroides",
                "children": []
              },
              {
                "text": "- Administraci√≥n simult√°nea de vitamina A y hierro ‚Üí respuesta m√°s r√°pida",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA DE\\NVITAMINA B6",
        "children": [
          {
            "text": "- Incluye piridoxal, piridoxina y piridoxamina",
            "children": []
          },
          {
            "text": "- Conduce a anemia microc√≠tica hipocr√≥mica",
            "children": []
          },
          {
            "text": "- Causas",
            "children": [
              {
                "text": "- Isoniazida ‚Üí interfiere con metabolismo de vitamina B6",
                "children": []
              },
              {
                "text": "- Estados de malabsorci√≥n",
                "children": []
              },
              {
                "text": "- Di√°lisis renal",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Corregible con dosis altas de piridoxina",
                "children": []
              }
            ]
          },
          {
            "text": "- Casos\\Nespeciales",
            "children": [
              {
                "text": "- 5-10% de pacientes sin deficiencia de vitamina B6 ‚Üí\\Nanemia siderobl√°stica con respuesta parcial a piridoxina",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA DE\\NRIBOFLAVINA",
        "children": [
          {
            "text": "- Efectos",
            "children": [
              {
                "text": "- Precursores eritroides vacuolados",
                "children": []
              },
              {
                "text": "- Aplasia eritrocitaria pura",
                "children": []
              },
              {
                "text": "- Actividad reducida de glutati√≥n reductasa de eritrocitos",
                "children": []
              },
              {
                "text": "- No se asocia con hem√≥lisis o lesi√≥n inducida por oxidante",
                "children": []
              }
            ]
          },
          {
            "text": "- Mecanismo",
            "children": [
              {
                "text": "- Efecto en la absorci√≥n de hierro",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Revierte con administraci√≥n de riboflavina",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA\\NDE TIAMINA",
        "children": [
          {
            "text": "- Caracter√≠sticas",
            "children": [
              {
                "text": "- S√≠ndrome raro de la ni√±ez",
                "children": []
              },
              {
                "text": "- Diabetes mellitus",
                "children": []
              },
              {
                "text": "- Sordera neurosensorial",
                "children": []
              },
              {
                "text": "- Anemia megalobl√°stica",
                "children": []
              },
              {
                "text": "- En ocasiones, trombocitopenia",
                "children": []
              }
            ]
          },
          {
            "text": "- Prevalencia",
            "children": [
              {
                "text": "- Ni√±os de ascendencia asi√°tica",
                "children": []
              }
            ]
          },
          {
            "text": "- Causa",
            "children": [
              {
                "text": "- Mutaci√≥n bial√©lica del gen SLC19A2 (cromosoma 1q23.3)",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Administraci√≥n de por vida de tiamina (25-100 mg/d√≠a)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA DE VITAMINA C\\N(√ÅCIDO ASC√ìRBICO)",
        "children": [
          {
            "text": "- Manifestaciones\\Nhematol√≥gicas",
            "children": [
              {
                "text": "- Anemia variable: macroc√≠tica, normoc√≠tica o microc√≠tica",
                "children": []
              },
              {
                "text": "- M√©dula √≥sea: hipocelular, normocelular o hipercelular",
                "children": []
              },
              {
                "text": "- Hematopoyesis megalobl√°stica (10% de pacientes)",
                "children": []
              },
              {
                "text": "- Anemia normoc√≠tica normocr√≥mica con reticulocitosis 5-10%",
                "children": []
              }
            ]
          },
          {
            "text": "- Mecanismos",
            "children": [
              {
                "text": "- Interacci√≥n con √°cido f√≥lico en generaci√≥n de √°cido tetrahidrof√≥lico",
                "children": []
              },
              {
                "text": "- Facilita absorci√≥n de hierro",
                "children": []
              },
              {
                "text": "- Manifestaci√≥n hemorr√°gica del escorbuto",
                "children": []
              },
              {
                "text": "- Mecanismos de defensa antioxidantes celulares comprometidos",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Responde con prontitud a administraci√≥n de vitamina C",
                "children": []
              },
              {
                "text": "- Requiere suficiente √°cido f√≥lico y hierro para respuesta",
                "children": []
              },
              {
                "text": "- Si anemia es macroc√≠tica, administrar folato con vitamina C",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA DE VITAMINA E\\N(Œ±-TOCOFEROL)",
        "children": [
          {
            "text": "- Factores de riesgo",
            "children": [
              {
                "text": "- Requerimiento var√≠a con contenido de √°cidos grasos poliinsaturados",
                "children": []
              },
              {
                "text": "- Lactantes con peso bajo al nacer",
                "children": []
              },
              {
                "text": "- Malabsorci√≥n cr√≥nica de grasa (fibrosis qu√≠stica, cirug√≠a bari√°trica)",
                "children": []
              },
              {
                "text": "- Enfermedad de c√©lulas falciformes",
                "children": []
              }
            ]
          },
          {
            "text": "- Manifestaciones",
            "children": [
              {
                "text": "- Anemia hemol√≠tica (4-6 semanas de edad)",
                "children": []
              },
              {
                "text": "- Alteraci√≥n morfolog√≠a eritrocitos",
                "children": []
              },
              {
                "text": "- Trombocitosis",
                "children": []
              },
              {
                "text": "- Edema del dorso de pies y √°rea pretibial",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Vitamina E revierte anormalidades",
                "children": []
              },
              {
                "text": "- Suplementos diarios de forma hidrosoluble en malabsorci√≥n",
                "children": []
              },
              {
                "text": "- En c√©lulas falciformes: 450 unidades/d√≠a ‚Üí disminuci√≥n c√©lulas falciformes irreversibles",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## DEFICIENCIA\\NDE COBRE",
        "children": [
          {
            "text": "- Funci√≥n",
            "children": [
              {
                "text": "- Absorci√≥n y utilizaci√≥n del hierro",
                "children": []
              },
              {
                "text": "- Mantiene hierro en estado f√©rrico para transporte de transferrina",
                "children": []
              }
            ]
          },
          {
            "text": "- Causas",
            "children": [
              {
                "text": "- Ni√±os malnutridos",
                "children": []
              },
              {
                "text": "- Lactantes y adultos con alimentaci√≥n parenteral",
                "children": []
              },
              {
                "text": "- Ingesti√≥n cr√≥nica de cantidades masivas de zinc",
                "children": []
              },
              {
                "text": "- Resecci√≥n g√°strica o cirug√≠a bari√°trica",
                "children": []
              }
            ]
          },
          {
            "text": "- Manifestaciones",
            "children": [
              {
                "text": "- Anemia microc√≠tica con hipoferremia",
                "children": []
              },
              {
                "text": "- Neutropenia",
                "children": []
              },
              {
                "text": "- Precursores eritroides vacuolados en m√©dula √≥sea",
                "children": []
              },
              {
                "text": "- No responde a terapia con hierro",
                "children": []
              },
              {
                "text": "- Anemia macroc√≠tica y sideroblastos en anillo ‚Üí similar a s√≠ndrome mielodispl√°sico",
                "children": []
              },
              {
                "text": "- Anormalidades neurol√≥gicas (mieloneuropat√≠a)",
                "children": []
              }
            ]
          },
          {
            "text": "- Diagn√≥stico",
            "children": [
              {
                "text": "- Nivel bajo de cobre s√©rico",
                "children": []
              },
              {
                "text": "- Ceruloplasmina s√©rica baja",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Oral: 0.2 mg/kg/d√≠a",
                "children": []
              },
              {
                "text": "- Intravenoso: 2.4 mg/d√≠a durante 6 d√≠as, luego semanal",
                "children": []
              },
              {
                "text": "- Suplementos orales: gluconato de cobre (8 mg/d√≠a)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "##\\NDEFICIENCIA\\NDE ZINC",
        "children": [
          {
            "text": "- Puede acompa√±ar a talasemia o enfermedad c√©lulas falciformes",
            "children": []
          },
          {
            "text": "- No produce anemia de forma aislada",
            "children": []
          },
          {
            "text": "- Manifestaciones",
            "children": [
              {
                "text": "- Retraso del crecimiento en ni√±os",
                "children": []
              },
              {
                "text": "- Deterioro cicatrizaci√≥n de heridas",
                "children": []
              },
              {
                "text": "- Alteraci√≥n percepci√≥n del gusto",
                "children": []
              },
              {
                "text": "- Deficiencias inmunitarias",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## ANEMIA POR\\NINANICI√ìN",
        "children": [
          {
            "text": "- Semiinanici√≥n",
            "children": [
              {
                "text": "- Anemia normoc√≠tica normocr√≥mica leve-moderada",
                "children": []
              },
              {
                "text": "- Precursores eritroides reducidos en m√©dula √≥sea",
                "children": []
              },
              {
                "text": "- Principalmente dilucional",
                "children": []
              }
            ]
          },
          {
            "text": "- Inanici√≥n completa\\N(9-12 semanas)",
            "children": [
              {
                "text": "- Anemia",
                "children": []
              },
              {
                "text": "- Hipocelularidad m√©dula √≥sea",
                "children": []
              },
              {
                "text": "- Disminuci√≥n requerimientos de ox√≠geno (estado hipometab√≥lico)",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Responde a reanudaci√≥n de dieta normal",
                "children": []
              },
              {
                "text": "- Realimentaci√≥n ‚Üí reticulocitosis y correcci√≥n d√©ficit hemoglobina",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## ANEMIA POR DEFICIENCIA DE PROTE√çNA\\N(KWASHIORKOR)",
        "children": [
          {
            "text": "- Caracter√≠sticas",
            "children": [
              {
                "text": "- Hemoglobina hasta 8 g/dL",
                "children": []
              },
              {
                "text": "- Normoc√≠tica y normocr√≥mica",
                "children": []
              },
              {
                "text": "- Anisocitosis y poiquilocitosis importantes",
                "children": []
              },
              {
                "text": "- Recuentos leucocitos y plaquetas normales",
                "children": []
              },
              {
                "text": "- M√©dula √≥sea normocelular o hipocelular",
                "children": []
              }
            ]
          },
          {
            "text": "- Tratamiento",
            "children": [
              {
                "text": "- Respuesta lenta a dietas ricas en prote√≠na",
                "children": []
              },
              {
                "text": "- Posible episodio aplasia eritroide tras 3-4 semanas (responde a riboflavina o prednisona)",
                "children": []
              },
              {
                "text": "- Pueden manifestarse deficiencias ocultas durante repleci√≥n (hierro, √°cido f√≥lico, vitaminas E y B12)",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "text": "## ALCOHOLISMO",
        "children": [
          {
            "text": "- Causas\\Nm√∫ltiples de\\Nanemia",
            "children": [
              {
                "text": "- Deficiencias nutricionales",
                "children": []
              },
              {
                "text": "- Sangrado gastrointestinal cr√≥nico",
                "children": []
              },
              {
                "text": "- Disfunci√≥n hep√°tica",
                "children": []
              },
              {
                "text": "- Anemia hemol√≠tica",
                "children": []
              },
              {
                "text": "- Hiperesplenismo por hipertensi√≥n portal",
                "children": []
              },
              {
                "text": "- Efectos t√≥xicos del etanol sobre eritropoyesis y metabolismo del folato",
                "children": []
              }
            ]
          },
          {
            "text": "- Tipos de anemia",
            "children": [
              {
                "text": "- Macroc√≠tica (com√∫n en alcoh√≥licos hospitalizados)",
                "children": []
              },
              {
                "text": "- Megalobl√°stica (por deficiencia √°cido f√≥lico)",
                "children": []
              },
              {
                "text": "- Cuadro \"dim√≥rfico\" (deficiencia hierro asociada)",
                "children": []
              },
              {
                "text": "- Macrocitosis leve (90% de alcoh√≥licos cr√≥nicos)",
                "children": []
              },
              {
                "text": "- Hemol√≠tica (s√≠ndrome de Zieve, anemia con acantocitos)",
                "children": []
              }
            ]
          },
          {
            "text": "- Particularidades",
            "children": [
              {
                "text": "- M√°s com√∫n en bebedores de vino/whisky que cerveza (fuente de folato)",
                "children": []
              },
              {
                "text": "- Trombocitopenia concomitante (efectos alcohol y deficiencia folato)",
                "children": []
              }
            ]
          }
        ]
      }
    ]
  },
  "related_maps": [
    {
      "id": "map_1673",
      "title": "DAPA-CKD (2020)\\NDapagliflozin And Prevention\\Nof Adverse outcomes in CKD\\N\\N‚≠ê iSGLT2 protege ri√±√≥n\\NINCLUSO SIN DIABETES\\N(Extiende beneficio a ERC no-DM)"
    },
    {
      "id": "map_1674",
      "title": "CREDENCE (2019)\\NCanagliflozin and Renal Events in Diabetes\\N\\nCanagliflozina reduce progresion ERC\\ny eventos CV en DM2 con nefropatia\\nNNTH 22 para outcome renal"
    },
    {
      "id": "map_1677",
      "title": "DAPA-HF (2019)\\NDapagliflozin in Heart Failure\\N\\nDapagliflozina reduce muerte CV y hospitalizacion IC\\nen IC-FEr CON y SIN diabetes\\NNNTH 21"
    },
    {
      "id": "map_1689",
      "title": "SPRINTT (2021)\\NSarcopenia and Physical\\NFragility in Older People:\\NMulti-component Treatment\\N\\n‚≠ê Ejercicio + nutrici√≥n reduce\\ndiscapacidad en fragilidad f√≠sica\\ncon sarcopenia"
    },
    {
      "id": "map_1710",
      "title": "SELECT (2023)\\NSemaglutide Effects on\\NCardiovascular Outcomes\\Nin Obesity without Diabetes\\N\\n‚≠ê Semaglutida reduce 20%\\Neventos CV en obesidad SIN DM"
    }
  ],
  "source_file": "Williams. ANEMIA ORIGINADA POR OTRAS DEFICIENCIAS NUTRICIONALES-2025-1.smmx",
  "created": "2026-02-07T15:42:58.223355"
}